SciClone Pharmaceuticals

Company Drug

SciClone Pharmaceuticals Doses First Patient in RRx-001 Phase III Study for SCLC

Fineline Cube Sep 6, 2022

China-based SciClone Pharmaceuticals Inc. (Nasdaq: SCLN) announced that the first patient has been dosed in...

Company Deals Drug

SciClone Licenses Menarini’s Vaborem to Tackle Drug-Resistant Infections in China

Fineline Cube Aug 17, 2022

SciClone Pharmaceuticals Inc (Nasdaq: SCLN), a China-based company since going private in 2017, announced a...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod